Generated by GPT-5-mini| Randy Schekman | |
|---|---|
![]() Bengt Oberger · CC BY-SA 4.0 · source | |
| Name | Randy Schekman |
| Birth date | 1948 |
| Birth place | San Francisco, California |
| Fields | Cell biology, Molecular biology |
| Workplaces | University of California, Berkeley, Howard Hughes Medical Institute |
| Alma mater | University of California, Los Angeles, University of California, San Diego |
| Known for | Vesicular trafficking, Secretory pathway |
| Awards | Nobel Prize in Physiology or Medicine (2013) |
Randy Schekman is an American cell biologist noted for elucidating mechanisms of vesicular trafficking and membrane transport in eukaryotic cells. His work on the secretory pathway in Saccharomyces cerevisiae and the identification of genes required for vesicle formation and fusion reshaped understanding across cell biology, molecular biology, and biochemistry. Schekman's research and leadership at institutions such as the University of California, Berkeley and the Howard Hughes Medical Institute contributed to a generation of scientists studying intracellular transport, membrane dynamics, and protein sorting.
Born in San Francisco, Schekman attended public schools before enrolling at the University of California, Los Angeles for undergraduate studies. He pursued graduate research at the University of California, San Diego under mentors associated with yeast genetics and molecular cell biology, engaging with techniques derived from laboratories linked to the National Institutes of Health and contemporary investigators in the United States. During his formative years he interacted with scientists from institutions such as Stanford University, Massachusetts Institute of Technology, and the Rockefeller University, shaping his approach to genetic and biochemical dissection of cellular processes.
Schekman's laboratory pioneered genetic screens in Saccharomyces cerevisiae to isolate mutants defective in the secretory pathway, leading to the identification of dozens of SEC genes required for vesicle budding, targeting, and fusion. His team characterized protein components including transport factors and coat proteins implicated in vesicle formation, integrating concepts from work on the Golgi apparatus, endoplasmic reticulum, and trans-Golgi network. These discoveries connected to parallel findings by researchers at the University of California, San Francisco, the European Molecular Biology Laboratory, and laboratories influenced by the biochemical studies of George Palade, Keith Porter, and Albert Claude. The SEC gene network elucidated by Schekman's group provided mechanistic links to SNARE-mediated membrane fusion described in studies from the University of California, San Diego and collaborative efforts across Princeton University and Columbia University.
Schekman applied genetic, biochemical, and electron microscopy approaches to define pathways for polarized secretion in yeast and to map conserved modules shared with mammalian systems studied at institutions like the National Institutes of Health and the Max Planck Society. His research intersected with work on vesicle coat complexes such as COPI, COPII, and clathrin from groups at the European Molecular Biology Laboratory, Harvard University, and Yale University, advancing models of cargo selection and vesicle budding.
After completing his doctoral studies, Schekman joined the faculty at the University of California, Berkeley, where he established a laboratory focused on membrane traffic and mentored students and postdocs who later held positions at universities including California Institute of Technology, Stanford University, University of Cambridge, Oxford University, and University College London. He served as an investigator of the Howard Hughes Medical Institute and held leadership roles within academic programs interacting with the American Society for Cell Biology, the National Academy of Sciences, and funding bodies such as the National Science Foundation. His collaborations extended to researchers at the Salk Institute for Biological Studies, Fred Hutchinson Cancer Research Center, and international centers including the Institute Pasteur.
Schekman's laboratory maintained long-standing ties with core facilities for electron microscopy and live-cell imaging at Lawrence Berkeley National Laboratory and collaborated with structural biology groups at the European Synchrotron Radiation Facility and the Max Planck Institute to integrate ultrastructural and molecular data.
Schekman received numerous honors recognizing his contributions, most notably the Nobel Prize in Physiology or Medicine in 2013, shared with colleagues for discoveries of machinery regulating vesicle traffic. He was elected to the National Academy of Sciences and the American Academy of Arts and Sciences, and received awards from organizations including the Lasker Foundation, the Royal Society, and the American Society for Cell Biology. Additional recognitions included membership in international academies such as the European Molecular Biology Organization and honors from foundations associated with scientific societies at Harvard University and Yale University.
Beyond the laboratory, Schekman became known for advocacy on scientific publishing, questioning practices at high-profile journals like Nature (journal), Science (journal), and Cell (journal), and promoting open-access models exemplified by initiatives such as eLife, PLOS Biology, and the Public Library of Science. He critiqued journal impact metrics and engaged with organizations including the Wellcome Trust, the Howard Hughes Medical Institute, and the Max Planck Society on reforms to peer review and evaluation criteria. Schekman also served on editorial boards and advisory panels for publishers, research funders, and university committees at institutions such as University of California, Berkeley and international consortia advancing data sharing and reproducibility.
Schekman has balanced a scientific career with roles in academic administration and public discourse, interacting with scientists and institutions across the United States, Europe, and Asia. His mentorship influenced trainees who joined faculties at institutions including Princeton University, University of California, San Francisco, Columbia University, and Duke University. He has participated in symposiums and lectures hosted by bodies such as the Royal Society, the National Academy of Sciences, and major universities, contributing to conversations on research integrity, scientific training, and publishing reform.
Category:American biologists Category:Nobel laureates in Physiology or Medicine Category:Members of the United States National Academy of Sciences